Life sciences company Revvity (NYSE:RVTY) is set to announce earnings results this Monday before the market opens. Last quarter, Revvity met analysts’ revenue expectations, reporting revenues of $698.9 million, a 2.2% increase from the previous year. Analysts expect this quarter’s revenue to grow by 4.7% to $763.5 million, with adjusted earnings of $1.58 per share. Analysts have generally maintained their estimates over the last 30 days. Peers in the life sciences tools & services segment, like Thermo Fisher and Danaher, have reported positive results. Revvity’s stock price is up 10.9% over the last month, with an average analyst price target of $116.19.

Read more at StockStory: Revvity (RVTY) Q4 Earnings: What To Expect